These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 30407703)

  • 1. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
    Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats.
    Keita AV; Carlsson AH; Cigéhn M; Ericson AC; McKay DM; Söderholm JD
    Neurogastroenterol Motil; 2013 Jun; 25(6):e406-17. PubMed ID: 23600853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.
    Bednarska O; Walter SA; Casado-Bedmar M; Ström M; Salvo-Romero E; Vicario M; Mayer EA; Keita ÅV
    Gastroenterology; 2017 Oct; 153(4):948-960.e3. PubMed ID: 28711627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
    Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
    Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A β-Glucan-Based Dietary Fiber Reduces Mast Cell-Induced Hyperpermeability in Ileum From Patients With Crohn's Disease and Control Subjects.
    Ganda Mall JP; Casado-Bedmar M; Winberg ME; Brummer RJ; Schoultz I; Keita ÅV
    Inflamm Bowel Dis; 2017 Dec; 24(1):166-178. PubMed ID: 29272475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial expression of vasoactive intestinal peptide in ulcerative colitis: down-regulation in markedly inflamed colon.
    Jönsson M; Norrgård O; Forsgren S
    Dig Dis Sci; 2012 Feb; 57(2):303-10. PubMed ID: 22143367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
    Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
    Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease.
    Jayawardena D; Anbazhagan AN; Guzman G; Dudeja PK; Onyuksel H
    Mol Pharm; 2017 Nov; 14(11):3698-3708. PubMed ID: 28991483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of VIPergic phenotype of enteric neurons by colonic biopsy supernatants from patients with inflammatory bowel diseases: Involvement of IL-6 in Crohn's disease.
    Soufflet F; Biraud M; Rolli-Derkinderen M; Lardeux B; Trang C; Coron E; Bruley des Varannes S; Bourreille A; Neunlist M
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28857361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.
    Mazumdar S; Das KM
    Am J Gastroenterol; 1992 Feb; 87(2):176-81. PubMed ID: 1370872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of free radical scavenging activity of vasoactive intestinal peptide in the attenuation of mitochondrial dysfunction to ameliorate dextran sulphate sodium-induced colitis in mice: Implications in ulcerative colitis.
    Spoorthi BC; More SS; Gautham SA; Ghosh S; Saha I; Maiti AK
    J Dig Dis; 2020 Dec; 21(12):711-723. PubMed ID: 33405317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased colonic peptide histidine-methionine in idiopathic inflammatory bowel diseases.
    Koch TR; Michener SR; Carney JA; Go VL
    Dig Dis Sci; 1988 Apr; 33(4):423-8. PubMed ID: 3349889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine.
    Jayawardena D; Guzman G; Gill RK; Alrefai WA; Onyuksel H; Dudeja PK
    Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G16-G25. PubMed ID: 28385693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome.
    Meira de-Faria F; Casado-Bedmar M; Mårten Lindqvist C; Jones MP; Walter SA; Keita ÅV
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14130. PubMed ID: 33797165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactobacillus casei ATCC 393 combined with vasoactive intestinal peptide alleviates dextran sodium sulfate-induced ulcerative colitis in C57BL/6 mice via NF-κB and Nrf2 signaling pathways.
    Zhu L; Qiao L; Dou X; Song X; Chang J; Zeng X; Xu C
    Biomed Pharmacother; 2023 Sep; 165():115033. PubMed ID: 37379640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.